London-based private equity firm CapVest has postponed a sale of French medical supplier Curium Pharma after prospective buyers lowered their bids due to ongoing market volatility, according to Bloomberg. CapVest was reportedly seeking at least $3 billion for the company, with Nordic Capital, Bain Capital and CVC Capital Partners said to be among its suitors. CapVest has backed Curium since 2017, when it helped create the company through the merger of IBA Molecular with a unit of Mallinckrodt.
Read the full article: Coronavirus Helps Scuttle $3B Curium Pharma Buyout //
Source: https://pitchbook.com/newsletter/coronavirus-helps-scuttle-3b-curium-pharma-buyout-RMe